By Tarun Sai Lomte Emerging research suggests certain dietary compounds may strengthen the body’s defences against ...

A new study reveals that the twin enzymes MNK1 and MNK2 play distinct roles in the brain, with one governing memory and the other social behavior.

As of Thursday, February 26, Aclaris Therapeutics, Inc.’s ACRS share price has dipped by 12.08%, which has investors ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

Neflamapimod, an experimental oral therapy from Cervomed, has been selected for inclusion in the U.K.-funded EXPERTS-ALS platform study.

Pfizer Inc. (NYSE: PFE) today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the ...

UK-based trial first to evaluate neflamapimod in ALS; first person with ALS expected to be dosed by end of 2026 Trial costs ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

An international team of scientists has shed light on the development of the malaria parasite and has identified a unique protein essential for its survival and transmission, which offers a promising ...

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

After a long trail race, some of your red blood cells may not bend the way they should. That matters because red blood cells have a tight job description.